Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01644253
Title Phase 1b Safety and Efficacy Study of TRU-016
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aptevo Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Augusta Georgia 30912 United States Details
Columbus Ohio 43210 United States Details
Eastern Regional Medical Center Philadelphia Pennsylvania 19124 United States Details
University of Pittsburgh Pittsburgh Pennsylvania 15232 United States Details
Greenville Health System Greenville South Carolina 29605 United States Details
Houston Texas 77030 United States Details
Swedish Cancer Institute,1221 Madison St. Seattle Washington 98104 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field